Cookson Peirce & Co’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,481
Closed -$781K 353
2026
Q1
$781K Buy
3,481
+383
+12% +$95.4K 0.03% 204
2025
Q4
$746K Buy
+3,098
New +$792K 0.03% 214
2020
Q4
Sell
-1,497
Closed -$257K 181
2020
Q3
$257K Buy
1,497
+220
+17% +$40.6K 0.02% 129
2020
Q2
$245K Sell
1,277
-480
-27% -$78.5K 0.02% 123
2020
Q1
$259K Sell
1,757
-3
-0.2% -$478 0.03% 121
2019
Q4
$273K Hold
1,760
0.02% 138
2019
Q3
$238K Buy
+1,760
New +$231K 0.02% 134
2013
Q3
Sell
-40,270
Closed -$1.82M 130
2013
Q2
$1.82M Buy
+40,270
New +$1.91M 0.53% 47

Other funds holding RMD

Cookson Peirce & Co's RMD Position: Q2 2026 in Review

Cookson Peirce & Co sold out of ResMed (RMD) in Q2 2026, closing a stake of 3,481 shares — an estimated $781K sold.

Cookson Peirce & Co first reported a position in RMD in Q2 2013 and held it in 8 quarters. The position peaked at $1.82M in Q2 2013. 196 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cookson Peirce & Co reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Cookson Peirce & Co sold 3,481 ResMed shares in Q2 2026, an estimated $781K.
  • Cookson Peirce & Co first reported a position in ResMed in Q2 2013 and held it in 8 quarters.
  • Cookson Peirce & Co's ResMed position peaked at $1.82M in Q2 2013.
  • 196 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.